High Potency Active Pharmaceutical Ingredients Market - Global Industry Analysis, Size, Growth, Share And Forecast, 2012 - 2018

In this research report Transparency Market Research analyzes the global high-potency active pharmaceutical ingredients market (HPAPI) along with market dynamics and present market condition. It also covers the market of high-potency active pharmaceutical ingredients types and application in different regions of the world namely, North America, Europe, Asia and RoW along with their sub segments. Moreover, the report provides detailed and in-depth analysis of the HPAPI market, with their estimated figures and forecast from 2012 to 2018, along with compound annual growth rate from 2012 to 2018.

The global high-potency active pharmaceutical ingredients market has shown favorable growth trend in the last few years and is expected to grow rapidly in the forecasted period. The demand of oncology products is further expected to drive the growth of this market. The high level of competition in this market is due to new entrants fragmenting the market. HPAPI market by type of synthesis has been covered in this report providing their estimates and forecast from 2012 to 2018. The drivers, restraints and opportunities have also been covered broadly in this report along with their impact analysis. These market dynamics will be highly helpful in taking corporate decisions related to the HPAPI market.

High potency active pharmaceutical ingredients (HPAPIs) are growing rapidly as compared to other segments of the healthcare industry. HPAPI are the compounds helpful in the treatment of respiratory disorders, treatment of cancer and hormonal imbalances. Growing oncology therapeutics market worldwide is the key factor driving the growth of this market.

High Potency Active Pharmaceutical Ingredients Market is a growing concept and is considered to be a boost to the pharmaceutical industry. Patented high potency drug development majorly dominates the HPAPI market. The branded sector constitutes the major share of this market but the patents of this branded sector are expected to expire in the coming few years that will help HPAPI manufacturers to cater to multiple clients by producing the generic version of the ingredients in bulk.

Some of the factors driving this market at a rapid growth rate are majority of blockbuster drugs nearing patent expiry, US government promoting generic drugs to reduce its medical burden, insurance companies preferring generic drugs over patented drugs for cost effectiveness and India and China with maximum DMFs with the US FDA.

However, a large number of competitors are entering this market making it highly fragmented which may slow down the growth of this market. Moreover, reduced R&D investments leading to low demand of HPAPIs and shortage of US FDA approved manufacturing sites are also likely to be the major restraints for the growth of the high potency active pharmaceutical ingredients market.

However, North America has been the largest market for high potency pharmaceutical ingredients as the country spends highly on the development of healthcare systems, whereas the European market has experienced several fluctuations in the past few years but is expected to grow rapidly in the near future due to rise in the demand of oncology drugs in this region.

Browse Report : http://www.transparencymarketresearch.com/high-potency-active-pharmaceutical-Ingredients-market.html

Read More

Seasonal Influenza Vaccines Industry In Top Seven Countries To 2018 - Next Generation Quadrivalent Vaccines To Dominate The Market By Offering Broader Protection Via Single Dose

GBI Research, the leading business intelligence provider, has released its latest research, Seasonal Influenza Vaccines Market in Top Seven Countries to 2018 Next Generation Quadrivalent Vaccines to Dominate the Market by Offering Broader Protection via Single Dose, which provides essential insights into seasonal influenza vaccines sales forecasts for the top seven countries, comprising the US, the UK, France, Italy, Spain, Germany and Japan until 2018. It also covers vaccination patterns and geographic distribution and offers a clear view of the regulatory landscape. Additionally, the report includes insights into the seasonal influenza vaccine R&D pipeline and gives profiles of promising vaccines, as well as exploring the competitive landscape through profiles for the top companies. Key trends in terms of M&A and licensing agreements are also analyzed.

Browse Report : Seasonal Influenza Vaccines Market In Top Seven Countries To 2018

GBI Research expects the market to grow at a Compound Annual Growth Rate (CAGR) of 3.9% during the 20112018 period from $2.9 billion in 2011 to $3.8 billion by 2018, driven by growing awareness, increasing vaccination coverage and rising government support for immunization against seasonal influenza. On the other hand, limited production capacity, high investment and strict regulations may act as barriers to entry.

The US seasonal influenza vaccine market is the most attractive of those covered in the report in terms of value. It is forecast to increase from $1.6 billion in 2011 to $2.2 billion in 2018 at a CAGR of 4.8%, due to the growth of the aging population, higher disease awareness and the fact that being vaccinated has become more convenient. The UK on the other hand has the most attractive market in terms of growth rate, forecast to grow at CAGR of 6.3% between 2011 and 2018. Germanys market is also attractive and is forecast to grow at a CAGR of 2.7% between 2011 and 2018 from $385.5m to $465m. The market in Japan is forecast to grow at CAGR of 1.6% between 2011 and 2018 to reach $621.5m by 2018, driven by the threat of pandemic influenza and higher awareness of influenza vaccination. The government-run influenza immunization program is also helping to increase vaccination coverage.

GBI Researchs analysis shows that the R&D pipeline for seasonal influenza vaccines comprises a high number of vaccines in early-stage development, many of which are new formulations or those that have been developed using the cell culture method. Late-stage vaccines are either quadrivalent vaccines or pediatric versions of those that have already been approved. The market is currently dominated by trivalent vaccines but will witness the launch of quadrivalent vaccines in the near future.

Read More : Seasonal Influenza Vaccines Industry

Scope

• Data and analysis on the seasonal influenza vaccine market in the top seven countries, comprising the US, the UK, France, Italy, Spain, Germany and Japan
• Market forecasts for seasonal influenza vaccines until 2018
• Market data on geographical landscape in terms of country, vaccination coverage, public and private contribution to the total number of doses, vaccine price and market size
• Key drivers and restraints that have had a significant impact on the market
• Regulatory landscape, including the approval process and an overview of the regulatory authorities in the top seven countries
• Competitive landscape of the seasonal influenza vaccine market in the top seven countries including top companies profiles, namely Sanofi, Johnson & Johnson, GlaxoSmithKline Biologicals, Novartis Vaccines and AstraZeneca
• Key M&A activities and licensing agreements that have taken place between 2009 and mid-2012

Reasons to buy

• Build effective strategies to launch pipeline products by identifying potential geographies
• Exploit in-licensing and out-licensing opportunities by identifying products that might fill portfolio gaps
• Develop key strategic initiatives by studying top competitors key strategies
• Develop market-entry and market-expansion strategies by identifying the markets poised for strong growth
• Reinforce R&D pipelines by identifying new target mechanisms able to produce safer and more efficacious first-in-class vaccines

Browse : http://www.businessresearchindustry.com/report/seasonal-influenza-vaccines-market-in-top-seven-countries-to-2018-next-generation-quadrivalent-vaccines-to-dominate-the-market-by-offering-broader-protection-via-single-dose.htm

Read More

Gastrointestinal Disorders Therapeutics Industry To 2018 - Novel Agents Targeting Irritable Bowel Syndrome (IBS), Chronic Constipation (CC) And Ulcerative Colitis (UC) To Reinvigorate The Market

GBI Research, the leading business intelligence provider, has released its latest research, Gastrointestinal Disorders Therapeutics Market to 2018 Novel Agents Targeting Irritable Bowel Syndrome (IBS), Chronic Constipation (CC) and Ulcerative Colitis (UC) to Reinvigorate the Market, which provides insights into the gastrointestinal disorders therapeutics market until 2018. 

Browse : Gastrointestinal Disorders Therapeutics Industry

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts. It provides in-depth analysis of the major diseases, comprising IBS, constipation, Crohns disease, UC, Gastroesophageal Reflux Disease (GERD) and Peptic Ulcer Disease (PUD). The report also gives the size of the generic share in the global gastrointestinal disorders therapeutics market and in those of the US, the top five countries of Europe, and Japan, as well as treatment usage patterns and geographical distribution. Additionally, it includes insights into the R&D product pipeline and explores the competitive landscape, looking at major players and including analysis of M&A, licensing agreements and co-development deals that have taken place in the past two years.

GBI Researchs analysis shows that the gastrointestinal disorders therapeutics market is set to witness high generic competition in the forecast period, as major drugs used in the treatment of the aforementioned disorders are set to expire, resulting in declining revenues and allowing generics to enter the market. Nevertheless, the market will witness steady growth due to the anticipated entry of innovative new drugs in the near future. Furthermore, strong R&D in IBS, constipation, Crohns disease and UC remains a key market driver.

Scope

• Data and analysis for the gastrointestinal disorders therapeutics markets in the leading geographies: the US; the top five countries of Europe, comprising the UK, Germany, France, Italy and Spain; Japan; and an overview of India, China and Australia
• Annualized market data for the gastrointestinal disorders therapeutics market from 2004 to 2010 and forecast to 2018
• Market data for the geographical and therapeutic landscapes, including size, share, annual cost of therapy, sales volume and treatment usage patterns for the diseased population, diagnosis population and prescription population
• Generic share in the global market and for each indication
• Key drivers and restraints that have had a significant impact on the market
• The competitive landscape of the global market, looking at key companies such as AstraZeneca, Takeda, Johnson & Johnson , Eisai, Abbott, Shire and Salix
• Key M&A activity and licensing agreements that took place between 2010 and 2012

Read Report : Gastrointestinal Disorders Therapeutics Market To 2018 

Reasons to buy

• Align product portfolios to the markets with high growth potential
• Build effective strategies to launch pipeline products by identifying potential geographies
• Exploit in-licensing and out-licensing opportunities by identifying products that might fill portfolio gaps
• Develop key strategic initiatives by studying top competitors key strategies
• Device a more tailored country strategy by understanding the key drivers, barriers and market potential for each indication
• Develop market-entry and market-expansion strategies by identifying the markets poised for strong growth
• Reinforce R&D pipelines by identifying new target mechanisms producing safer and more efficacious FIC molecules

Browse : http://www.businessresearchindustry.com/report/gastrointestinal-disorders-therapeutics-market-to-2018-novel-agents-targeting-irritable-bowel-syndrome-ibs-chronic-constipation-cc-and-ulcerative-colitis-uc-to-reinvigorate-the-market.htm

Read More

Downstream Processing Market In Biopharmaceuticals - Adoption Of Disposable Technology At Improved Economies Of Scale To Optimize Production Efficiency And Cost-Effectiveness

GBI Research, the leading business intelligence provider, has released its latest research, Downstream Processing in Biopharmaceuticals Adoption of Disposable Technology at Improved Economies of Scale to Optimize Production Efficiency and Cost-effectiveness, which provides key data, information and analysis of the Contract Manufacturing Organization (CMO) industry, and the downstream processing and reagent market. 

Browse: Downstream Processing Market

The report provides comprehensive insight into the size of the CMO market, the downstream processing and reagent market and includes forecasts, key reasons for outsourcing, market characterization, downstream process in biopharmaceuticals, major reagents, reagent suppliers and the reagent market related to downstream processing, profiles of key equipment players, key reagent players and key CMO players, drivers and restraints and deals analysis.

This report is built using data and information sourced from proprietary databases, primary and secondary research and uses in-house analysis from GBI Researchs team of industry experts.

Major CMOs offer both upstream and downstream manufacturing functions equally. In addition to manufacturing in biopharmaceutical production, they also offer clinical trials, logistics, packaging, and even marketing. According to industry experts, almost 60% of the CMO market in dominated by manufacturing functions, out of which more than 50% is dominated by the downstream process. GBI research suggests that the CMO market size for downstream processing is set to grow at a Compound Annual Growth Rate (CAGR) of 15.1%, which is more than the growth in the overall CMO biopharmaceutical market.

Browse Report : Downstream Processing Market In Biopharmaceuticals

Scope

• A detailed overview of the downstream processing, CMO industry and reagent market.
• Annualized market data and forecasts for the downstream processing, CMO industry and reagent market.
• A detailed overview of key reasons behind outsourcing, outsourcing service models and key drivers and restraints of the market.
• A detailed discussion of the downstream processing.
• Company profiles of major equipments suppliers, CMOs and reagent players including the key services offered by them and their financial information. 
• Analysis of the Merger and Acquisition (M&A) deals involving key companies

Reasons to buy

• Develop market-entry and market expansion strategies by identifying areas for high growth and opportunities.
• Understand the factors shaping the downstream processing, CMO industry and reagent market.
• Identify the top players in the major equipment suppliers, CMO and reagent market, their financial revenues, geographical presence and key services offered. 
• Analyze the key geographies that are lucrative markets for the downstream processing and as well as CMOs.
• Analyze the trends in licensing and M&A deals and explore potential investment opportunities
• Understand upcoming trends that are poised to drive the future growth of the downstream processing

Browse : http://www.businessresearchindustry.com/report/downstream-processing-in-biopharmaceuticals-adoption-of-disposable-technology-at-improved-economies-of-scale-to-optimize-production-efficiency-and-cost-effectiveness.htm

Read More

Leukemia Therapeutics Industry To 2018 - Strong Late-Stage Pipeline To Sustain Branded Drugs' Major Market Share

GBI Research, the leading business intelligence provider, has released its latest research Leukemia Therapeutics Market to 2018 Strong Late-stage Pipeline to Sustain Branded Drugs' Major Market Share which provides insights into leukemia therapeutics market until 2018 for four major indications. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts. 

Browse : Leukemia Therapeutics Industry To 2018

The report provides an in-depth analysis of the major leukemia indications including acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myelocytic leukemia (AML) and chronic myelocytic leukemia (CML). The report examines the global leukemia diseases treatment usage patterns. In addition, the geographical distribution of leukemia therapeutics and markets across the US, the top five countries of Europe and in Japan are provided in the report. The report also includes insights into the leukemia therapeutics R&D product pipeline and explores the competitive landscape including major players in the leukemia therapeutics market. Finally, the report also includes analysis on Mergers and Acquisitions (M&As) and licensing agreements that took place in leukemia therapeutics market.

In 2011, the leukemia therapeutics market for four major leukemia indications was estimated at $4.0 billion, indicating a compound annual growth rate (CAGR) of 21.0% since 2004. GBI Research forecasts the market to grow at a CAGR of 9.5% between 2011 and 2018 to reach to $7.6 billion by 2018. The four indications covered are treatment of acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myelogenous leukemia (AML) and chronic myelogenous leukemia (CML). The historic growth in major markets such as the US, the top five countries of Europe and Japan were driven mainly by the increasing prevalence and prescription population as well as launch of newer brands such as Sprycel, Tasigna, Clolar and Arranon with no major patent expirations. The US was the leading market with an estimated sales value of $1.8 billion in 2011 and an approximate share of 44.3%. The US market is expected to grow at a CAGR of 10.0% between 2011 and 2018 to record sales value of $3.5 billion in 2018. The top five countries of Europe together contributed to sales worth $1.5 billion in 2011, accounting for an approximate share of 37.9%. The top five countries of Europe are expected to record sales worth $3.1 billion by the year 2018, at a CAGR of 10.3%. Japan, in 2011, contributed $720m to the global market increasing at a CAGR of 20.8% from 2004. It accounts for an approximate share of 17.8%. Growing at a CAGR of 6.1% between 2011 and 2018, the market is expected to record sales worth $1.1 billion by 2018.

Browse : Leukemia Therapeutics Market

Scope

• Data and analysis on the leukemia therapeutics market in the leading geographies of the world the US, Japan, the UK, Germany, France, Italy and Spain 
• Annualized market data for the leukemia therapeutics market from 2004 to 2011, with forecasts to 2018
• Market data on the geographical landscape and therapeutic landscape, including market size, market share, annual cost of therapy, sales volume and treatment usage patterns such as disease population, treatment seeking population, diagnosis population and prescription population
• Key drivers and restraints that have had a significant impact on the market
• The competitive landscape of the global leukemia therapeutics market including top companies benchmarking. The key companies studied in this report are Novartis AG, GlaxoSmithKline plc (GSK), Genzyme Corporation, Bristol-Myers Squibb Company (BMS) and Eisai Co., Ltd.
• Key M&A activities and licensing agreements that took place in 2009 and 2011 in the leukemia therapeutics market.

Reasons to buy

• Align your product portfolio to the markets with high growth potential. 
• Build effective strategies to launch their pipeline products by identifying potential geographies. 
• Exploit in-licensing and out-licensing opportunities by identifying products that might fill their portfolio gaps. 
• Develop key strategic initiatives by studying the key strategies of top competitors. 
• Device a more tailored country strategy through the understanding of key drivers and barriers and market potential of each indication. 
• Develop market-entry and market expansion strategies by identifying the geographic markets poised for strong growth. 
• Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules which are safer and more efficacious.

Browse Report : http://www.businessresearchindustry.com/report/leukemia-therapeutics-market-to-2018-strong-late-stage-pipeline-to-sustain-branded-drugs-major-market-share.htm

Read More

Biobanks Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018

Biobanks is a collection or storation of blood and cell samples from a large number of people. Biobank collection denotes its use in medical field and research. The global biobank industry is segmented into different sectors such as human tissue banking, or population banking, stem cell banking, commercial biobanks, private cord banking, academic collections and other services such as DNA and RNA storage.

The global biobanks market was USD 142.million in 2011 and it is forecasted that this market will reach USD 216.3 million in 2018 with the compound annual growth rate of 5.4 % from 2011 – 2018. This market witnessed an increased trend of mergers and acquisitions among vendors. The recent example of this trend in the biobank market was that in 2011 when Thermo Fisher acquired Dionex Corp. This kind of collaboration of public and private banks is expected to increase in the coming years.

Read More: Biobanks Market

This market will also be driven by the political and scientific environment, increase in prevalence of chronic diseases such as cardiovascular disease, neurovascular disease, cancer, diabetes and respiratory disease, government funding and public awareness. Therefore, many pharmaceutical and biotech companies are using biobanks to develop new drugs for the treatment of chronic diseases which occur due to unhealthy diets, physical inactivity, alcohol consumption, and smoking.

However, this market could also face challenges due to lack of standardized and quality biospecimens. The private sector biobanks market was USD.42.4.million in 2010 and it is projected that this market will reach market value of USD 93.7 million in 2018.

The U.S and Europe have the largest market size in biobanks. However, the rapid growth in population in Asia Pacific countries will affect the market of the developed countries. Europe is the largest biorepositories market due to the huge demand from Netherlands, Italy, Germany U.K and several other countries.

Browse More Market Reports On Pharmaceutical Market Here

The biobanks market is dominated by some key vendors who accounted for more than seventy percent market share. These vendors include Thermo Fischer Scientific Inc, New Brunswick Scientific Co. Inc., Beckman Coulter Inc and ,Tecan AG. Thermo Fisher is the world leader in the biobanking market providing healthier, cleaner and safer solutions to patients. There are some other names in this market as well, such as TAP Biosystems, NEXUS Biosystems, BioKryo GmbH and others.

This market research report analyzes important market segments, and major geographies. This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Inquire before Buying OR Buy your copy of this report @: http://www.transparencymarketresearch.com/biobanks-market.html

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a technological growth map over time to understand the industry growth rate
• It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides an overview of the pricing trend and its impact on the market

For More Info Visit us @: http://www.transparencymarketresearch.com

About Us:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us:

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
http://www.transparencymarketresearch.com

Read More

Chromatography Market - Global Scenario, Trends, Industry Analysis, Size, Share and Forecasts, 2012 - 2017

Chromatography Market is Expected to Reach USD 8.9 Billion Globally in 2017: Transparency Market Research

According to a new market report published by Transparency Market Research "Chromatography Market - Global Scenario, Trends, Industry Analysis, Size, Share and Forecasts, 2012 - 2017," the global chromatography market was worth USD 6.6 billion in 2011 and is expected to reach USD 8.9 billion in 2017, growing at a CAGR of 4.1% from 2011 to 2017. In the overall global market, the U.S. is expected to maintain its lead position in terms of revenue till 2017. The U.S. is expected to enjoy 35.2% of the global chromatography market revenue share in 2017 followed by Europe.

Browse the full report at http://www.transparencymarketresearch.com/chromatography-market.html

The chromatography market is driven by growing environmental and safety concerns, rise in crime rate, safety and security of human life and rise in the number of cancer diagnosis. Globally, chromatographic techniques are used for separation of complex mixtures, detection of illicit drugs, enhancing environmental conditions with reduction in the poisonous content and production of medical drugs with exact chemical composition.

Chromatography is broadly categorized into three types comprised of liquid, gas and other chromatography techniques. Other techniques include HPLC, UHPLC, Ion exchange, LPLC, Flash, TLC and Chemical Sensor chromatography. In developed as well as in developing economies, the market is shifting towards advanced chromatographic technologies for e.g. ion exchange chromatography. However, liquid and gas chromatographic techniques will continue to sustain in the market with low cost and reimbursement facility in the overall market with low market growth rate in future.

Over the last decade, demand for advanced and innovative chromatographic technologies has increased considerably due to higher adoption of ion exchange and flash chromatography. Advanced chromatography includes ion exchange technology which helps in optimum usage of low solvent, producing high resolution output. The market for advanced chromatography was USD 1.0 billion in 2011 and is expected to reach USD 1.4 billion in 2017.

This research is specially designed to estimate and analyze the demand and performance of chromatography in a global scenario. The research provides in-depth analysis of chromatographic machine manufacturers, product sales, and trend analysis by segments and demand by geography. The report covers all the major product segments of theglobal chromatography market and provides in-depth analysis, historical data and statistically refined forecast for the segments covered. The study presents a comprehensive assessment of the stakeholder strategies and winning imperatives for them by segmenting the global chromatography market.

About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Read More

SNP Genotyping And Analysis Markets And The Future Of Snps In Personalized Medicine

SNP (single nucleotide polymorphism) analysis is the most common type of genetic variation between human beings and can be ideal for identifying the correlation between genotype and behavior of living organisms. Due to this reason, SNP analysis represents one of many pathways to personalized medicine. SNP analysis is used in different fields for specialized purposes; however, diagnostics and pharmacogenomics are the most promising applications of single nucleotide polymorphism. 

 Read More : SNP Genotyping Market

The SNP genotyping and analysis market is forecasted to witness double digit growth in equipment sales, chemicals and software with the introduction of more refined chips in the market with the ability to measure uncommon variants. SNP analysis is becoming popular for identifying variations in DNA sequences due to various reasons as 

• SNPs are available in bulk and account for about 80% of genetic variation in terms of quantity 
• They are stable through the generations 
• They are easy to score

Prices and amount of content provided in SNP products continue to improve with the dropping prices of genotype on the order of ten-fold every two years. 

 

SNP genotyping can only analyze the variants that are provided on chips. Despite recent technological challenges faced by this industry, there is still strong growth potential and money in this market. The need to find rare genotype variants will require new chips and more samples which are resulting in greater use of machines and chemicals in the analysis process. New microarray chips with more DNA probes are making their way into the industry as they are capable of measuring more variants. Development of these microarray chips will lead to new surge in projects. 

 

Market Segmentation Based on Applications

• Life Science Research 
• Pharmaceuticals/ Pharmacogenomics
• Agriculture/ Breeding
• Diagnostics

The research report titled “SNP Genotyping and Analysis Markets and the Future of SNPs in Personalized Medicine” analyzes the SNP genotyping market based on its market segments and major geographies. This report provides comprehensive analysis of current market trends, market growth drivers, factors limiting market growth, market structure, and market projections for upcoming years. The report also provides analysis of recent developments in technology, Porter’s five force model, and complete company profiles of top industry players. 

 

It includes review of micro and macro factors significant with respect to existing market players and new entrants with value chain analysis. 

 

Geographies analyzed under this research report include 

• North America
• Asia Pacific 
• Europe
• Rest of the World 

Major Players 

 

Some of the key players dominating this market are Affymetrix, Applied Biosystems, Beckman Coulter, CombiMatrix, GE Healthcare, Illumina, LI-COR Biosciences, Roche Applied Science, Sequenom, and others. 

Reasons for Buying this Report 

• This research report provides forward looking perspective on major market forces driving and restraining market growth 
• Report provides complete analysis of major competitors and their strategies
• Report provides pin-point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of industry trends
• It provides clear understanding of key product segments and competitive environment 
• It provides distinctive graphics and exemplified SWOT analysis of major industry segments 
• Report provides technological growth map over time and explains its impact on industry 

Browse : http://www.transparencymarketresearch.com/snp-single-nucleotide-polymorphism-market.html

Read More

Peptide Therapeutics Market - Global Industry Analysis, Market Size, Market Share and Forecasts, 2012 - 2018

Peptide therapeutics is evolving as a promising field over the past few years as a result of continuous research and developments in the field for developing new and effective drugs. New delivery techniques and manufacturing technologies coupled with intensified research and development programs is resulting in the approval of new peptide based drugs. 

Peptide therapeutics is the best option in recombinant medicines due to their low toxicity, high specificity, and much lower molecular weight which makes it easier to prepare dosage plans for patients. Improvements in manufacturing process and delivery systems are triggering the growth of this industry. 

Many large pharmaceutical companies are funding research and developments in this field which is further creating new opportunities for development of this industry. Emerging sectors of this industry like anti-infectives, vaccines, and central nervous system targeting peptides are well set for development of a new class of drugs. 

 

Read More: Peptide Therapeutics Market

Market Segmentation

Segmentation Based on Product

• Anticancer Peptides 
• Receptor Interacting Peptides
• Anti-Microbial Peptides
• Antiviral

Peptide therapeutics market analyzes this market based on its market segments and geographies covered. Major geographies analyzed under this research report include 

• North America 
• Europe 
• Asia Pacific 
• Rest of the World 

This report includes comprehensive analysis of current trends in market, industry growth drivers, factors affecting market growth, market structure, and industry projections for upcoming years. This report also includes detailed analysis of technological improvements in the field, Porter’s five force model analysis, and complete company profiles of top industry players. 

The report provides review of micro and macro factors significant with respect to new entrants and existing market players with value chain analysis. 

Major Players 

Some of the major players dominating this market are Affymax, Amylin Pharmaceutical Inc, AM-Pharma, Angstrom Pharmaceuticals, Argolyn Biosciences, Demegen, Enanta Pharmaceuticals, Helix Biomedix, Jerini Pharmaceuticals, PPL Therapeutics, ProCyte Corporation, Targeted Molecule Corporation, Theratechnologies, Zengen Inc, and others. 

Reasons for Buying this Report 

• This research report provides overview of major market forces driving and restraining market growth 
• It provides clear understanding of changing competitive dynamics and keeps you ahead of competitors
• Report provides technological growth map over time and explains its impact on market 
• It helps in making informed business decisions by making in-depth analysis of market 
• It provides distinctive graphics and exemplified SWOT analysis of major industry segments 
• Report provides detailed analysis of major competitors and their strategies 
• It also provides up-to-date analysis of latest trends in market and helps you stay updated with recent technological improvements.

Inquire before Buying OR Buy your copy of this report @:
http://www.transparencymarketresearch.com/peptide-therapeutics-market.html

Read More

Synthetic Biology Market - Global Industry Analysis, Size, Share and Forecasts, 2012 - 2018

The global market for synthetic biology is estimated to grow to $4.5 billion over the year 2015 owing to the developments in fields like biomedicine, biopharmaceutical synthesis, energy and environment, biosecurity, sustainable chemical segment, and biomaterials. Significant investments by major companies and emergence of new players in the market are also expected to boost the growth of this industry. 

Synthetic biology is the fastest growing segment of the biotechnology field having number of applications. Synthetic biology provides significant number of near future commercial opportunities. Despite its emerging status, the list of applications is continuously growing. Some of these major applications include chemicals, enzymes, synthetic genes and other DNA parts, pharmaceuticals, biofuels, and chassis microorganisms among others.

Current developments in technologies like DNA synthesis and sequencing, specialty media, and bioinformatics, and the need for renewable feedstock are driving the market for synthetic biology. Rapid developments in this field are creating unique market opportunities and contributing to the growth of this field. 

Synthetic biology is gaining tremendous recognition as a transformative technology as it has the ability to address food storage and security issues as well as handle other threats like climate change, energy shortage, and water deficits. 

 

Read More: Synthetic Biology Market

Market Segmentation

Application Segments 

• Energy and Chemicals
• Biotechnology and Pharmaceuticals 
• Research and Development

Market Segments 

• Enabling Products
• Biologic Components
• Integrated Systems 
• Enabled Products

The research report on the synthetic biology market analyzes this market depending on its market segments and major geographies. The geographies analyzed under this research report are

• North America
• Europe
• Asia Pacific 
• Rest of the World 

This research report is a comprehensive analysis of current industry trends, industry growth drivers, restraints, industry capacity, market structure, and market projections for upcoming years. The report also includes analysis of technological developments in the market, Porter’s five force model analysis, and complete company profiles of top industry players. 

It provides review of micro and macro factors significant with respect to new entrants and existing market players with value chain analysis. 

Major Players 

Major players dominating this market are Amyris Biotechnologies Inc., ATG Biosynthetics GmbH, Blue Heron Biotechnology Inc., Chromatin Inc., Draths Corp., febit Synbio GmbH, GENEART AG, GenScript USA Inc., Joule Biotechnologies Inc., LC Sciences, LS9 Inc., OPXBIO Inc., Solazyme Inc., Sloning BioTechnology GmbH, Synthetic Genomics Inc., Verdezyne Inc, and others.

 

Reasons for Buying this Report 

• The report provides distinctive graphics and exemplified SWOT analysis of major industry segments 
• It provides pin-point analysis of changing competition dynamics and keeps you ahead of competition 
• This research report provides forward looking perspectives on major market forces responsible for driving and restraining market growth
• It provides comprehensive analysis of major competitors and their strategies 
• It provides up-to-date analysis of current market trends and keeps you updated with technological changes in industry 
• Report provides clear understanding of key product segments and competitive environment 
• It provides technological growth map over time and explains its impact on industry.

Inquire before Buying OR Buy your copy of this report @:
http://www.transparencymarketresearch.com/synthetic-biology-market.html

Read More

Regenerative Medicines Market - Global Industry Analysis, Market Size, Market Share and Forecasts, 2012 - 2018

The global regenerative medicines market is forecasted to reach the market value of $1.4 billion over the year 2015 powered by increasing focus on stem cell research, aging baby boomers, greater usage of non-autograft products, and increasing investments in research and development activities. 

Regenerative medicine industry is assumed to be the next generation technology to revolutionize the medical system in the upcoming years. This industry is still in growing stage in terms of commercial applications, with a number of available products being limited to the field of orthopedics. A majority of products in other therapeutic fields are in preclinical or early clinical assessment stage. Support from governments around the world and technological breakthroughs are expected to drive the market growth for the regenerative medicines industry. 

Aging population with various age related cell dysfunctions provide a ready market for new therapies based on tissue engineering and regenerative medicines. Advancements in biological sciences are drastically impacting the regenerative medicine market in a positive way. Growing awareness about the use of regenerative medicines and increasing usage of non-autograft products is stimulating the growth of this market. Also, rising investments in research and development activity and improvements in regenerative equipments is further propelling the growth of this market. 

 

Read More: Regenerative Medicines Market

Market Segmentation

• Tissue Engineering
• Stem Cell Therapy
• Nanoscience
• Bioengineering 

Application Segments 

• Cardiovascular Diseases
• Diabetes
• Cancer
• CNS Diseases
• Eye Diseases

Regenerative medicines market analyzes this market depending on its segments and major geographies. Geographies analyzed under this research report are

• North America 
• Asia Pacific
• Europe
• Rest of the World 

This report includes comprehensive analysis of 

• Current market trends
• Industry growth drivers
• Restraints 
• Market structure 
• Market projections for the near future 

This report also includes detailed analysis of technological improvements in the field, Porter’s five force model analysis, and complete company profiles of top industry players. 

The report provides review of micro and macro factors significant with respect to new entrants and existing market players with value chain analysis. 

Major Players 

Some of the major players dominating this market are Aastrom Biosciences Inc., Advanced Cell Technology Inc., Athersys Inc, Amgen Inc., Bioheart Inc., Cytori Therapeutics Inc., Celgene Corporation, Geron Corporation, Genzyme Corporation, Osiris Therapeutics, Japan Tissue Engineering Co. Ltd., ThermoGenesis Corporation, and others. 

Reasons for Buying this Report 

• Report provides technological growth map over time and explains its impact on market 
• It helps in making informed business decisions by making in-depth analysis of market 
• It provides distinctive graphics and exemplified SWOT analysis of major industry segments 
• It also provides up-to-date analysis of latest trends in market and helps you stay updated with recent technological improvements 
• It provides clear understanding of changing competitive dynamics and keeps you ahead of competitors
• This research report provides overview of major market forces driving and restraining market growth 
• Report provides detailed analysis of major competitors and their strategies.

Inquire before Buying OR Buy your copy of this report @:
http://www.transparencymarketresearch.com/regenerative-medicines-market.html

Read More

RFID In Healthcare Market - Global Industry Analysis, Market Size, Share & Forecast, 2011 - 2017

Radio frequency identification (RFID) is a wireless technology becoming widely popular in various applications. RFID technology employed in healthcare settings may help in keeping track of medical staff’s compliance with policies to inventories they use. Staff tracking measures is the most common application of RFID technology; however, this technology is used in number of other applications in healthcare sector. 

RFID technology involves use of small ‘tag’ devices that radiates radio signals which are received by RFID receivers. This tag is read when it is in the range of the receiver (reader). Information is managed by a computer and it allows the user to interact with the data. As this technology does not involve data entry operations and they enhance mobile healthcare industry, this market is expected to witness significant growth in the coming few years. 

 

To BUY This Report Kindly Visit Us @:

http://www.transparencymarketresearch.com/rfid-in-healthcare.html

With nearly two million people developing hospital acquired infections annually, hand washing compliance is emerging as one of the major application sectors for RFID devices. When the staff member approaches the soap dispenser, the RFID system will read the RFID encoded badge and record the details of the person in the system. Owing to its increasing use in healthcare industry, the global market for RFID in healthcare is expected to grow at the compounded annual growth rate of 29.6% during the forecasted period. RFID sensors are used for tracking sleep pattern of patients; RFID is also used in security applications in the healthcare and pharmaceutical industry. 

 

Market Segmentation

• Pharmaceutical/Blood Product Distribution and Tracking 
• Patient/Medical Staff Identification and Tracking 
• Medical Asset Tracking and Locating 
• Implantable Device RFID use 

Other areas (including medical documents and patient records)

The research report on the global market for RFID in healthcare analyzes the RFID market based on its market segments and major geographies. Geographies analyzed under this research report include 

• North America
• Asia Pacific 
• Europe
• Rest of the World 

This report provides comprehensive analysis of current market trends, market growth drivers, factors limiting market growth, market structure, and market projections for upcoming years. The report also provides analysis of recent developments in technology, Porter’s five force model, and complete company profiles of top industry players. It includes review of micro and macro factors significant with respect to existing market players and new entrants with value chain analysis. 

Major Players 

Some of the key players dominating this market are 3M, Alien Technology, Blue Vector, Hewlett-Packard, International Business Machines (IBM), Intermec Inc., Motorola, PositiveID, Solstice Medical, SupplyScape, Tagsys Inc., Versus Technology, Zebra Technologies, and others. 

Reasons for Buying this Report 

• The report provides technological growth map over time and explains its impact on industry 
• It provides distinctive graphics and exemplified SWOT analysis of major industry segments 
• The report provides complete analysis of major competitors and their strategies
• It provides clear understanding of key product segments and competitive environment 
• The report provides pin-point analysis of changing competition dynamics and keeps you ahead of competitors
• This research report provides forward looking perspectives on major market forces driving and restraining market growth 
• It helps in making informed business decisions by having complete insights of the market and by making in-depth analysis of industry trends.

For more information kindly visit:
http://www.transparencymarketresearch.com/rfid-in-healthcare.html

Read More

According to a new report published by Transparency Market Research "Weight Management Market by Services, Supplements, Diet, Equipment and Devices: Global Analysis And Forecast (2007 - 2015)"Global Weight Management Market is estimated to be USD 385.1 billion in 2010 and expected to reach USD 650.9 billion in 2015 at a CAGR of 9.4% over the period 2010 to 2015.

Equipment & Devices segment accounted for the largest share at 37.7%of weight management market in 2010. Weight management services will be the fastest growing segment at 13.4% CAGR during 2010 to 2015. Weight management services segment will be worth USD 205.2 billion in 2015.

Browse : Weight Management Market

Over the past two decades, the overweight and obese population has nearly doubled and this is showing an increasing trend globally. Being overweight and obese may lead to the occurrence of diabetes, heart diseases and cancer. Not only the developed countries, but also the developing nations have now become the victim of this context of enormous interest for every government. 

The costs associated with treating these ailments are estimated to be substantially higher than the costs associated in taking precautions vide the weight management programs available these days.

Weight management industry is expected to touch a USD 650 billion mark by the year 2015. This industry is the key to open doors for opportunities for the not only the overweight and obese people, but also the health conscious individuals. 

This report provides a multi-dimensional view of the "weight management services" that are a subset of the weight management industry. This subsector consists of professional services, slimming centers and hospitals involved in the weight loss procedures such as invasive and non-invasive surgeries. In the realm of weight management services, there exists a limitless possibility that propels this segment to grow at CAGR of 13.5% (2007 - 2015E) and in value terms USD 200 billion by 2015. This is a major contributor in the weight management services industry with 35% of total potential. Other subsectors contributing to the remaining stake of 65% includes weight loss drugs, supplements, diet foods, replacement foods, beverages, and exercise devices and equipment.

North America is the leader in terms of global market share and growth in the weight management industry with revenue market revenue of USD 147.8 billion in 2010. Second rung is Europe with many people opting for weight management programs in the recent times and this region is growing at a comparable growth rate of North America. The Asiahas the most promising growth potential for the weight management industry in the near-and-far future is where the people are aggressively opting for westernized lifestyles and at the same time has access to more disposable incomes. However, our studies reveal that the Asians are quickly opting for health awareness initiatives making this market more attractive for the companies in this industry.

Browse : Weight Loss Market

Scope and Overview

The objective of the study on "Weight Management Market by Services, Supplements, Diet, Equipment and Devices: Global Analysis and Forecast" is to gain detailed market insights forkey Weight Management segments. The market is analyzed on the basis of growth trends, ongoing developments, market penetration and revenue share.The report also covers the strategies followed by "Weight Management Market" players.

Segmentation & Analysis

The report segments and analyzes the "Weight Management Market" on the basis of following sub-categories:

• Geographic Markets
  • U.S.
  • Europe
  • Asia &RoW
    • India
• By Segment
  • Weight Management Services
  • Weight Loss Supplements/Drugs
  • Food (diet) & Beverages
  • Equipment & Devices
• Services Segmentation
  • Food & Diet Segment
    • Organic & Herbal Food Chain
    • Diet Food Services
  • Weight Loss Segment
    • Slimming Resorts
    • Weight Loss program
    • Attitudinal Transformation Programs
  • Health Clubs
  • invasive & non-invasive surgery
    • invasive Surgery
      • Liposuction Surgery
      • Bariatric Surgery
  • Professional Services
  • Dietary services & consultation

This section provides in-depth analysis of Weight Management Services Market size and growth forecast for each sub segment, driving factors and challenges prevailing in the overall and at the micro market levels, and opportunities and future outlook for all the levels.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Browse full report athttp://www.transparencymarketresearch.com/weight-management-market.html 

Read More

Catheters (Cardiovascular, Specialty, Urological, Neurovascular, and Intravenous) Market Will Reach USD 33.3 Billion Globally in 2017

According to a new market report published by Transparency Market Research "Catheters (Cardiovascular, Specialty, Urological, Neurovascular, and Intravenous) Market - Global and China Forecast, Share, Size, and Industry Analysis (2010 - 2017)"; global catheters market was worth USD 20.4 billion in 2011 and is further expected to reach USD 33.3 billion in 2017, growing at a CAGR of 8.5% from 2011 to 2017. The cardiovascular catheter was the largest market segment at USD 8.3 billion in 2011. Globally, North America was the largest regional market with 44.3% share in 2011; however European region is expected to take the lead position post 2016.

Browse : Catheters Market

The global catheters market is expected to reach USD 22.6 billion in 2012. Aging population in both developed and emerging markets, patient's choice for minimally invasive procedures, and product innovations are key growth drivers for the market. The catheter devices market is segmented into cardiovascular, specialty, urological, neurovascular, and intravenous catheters. Among all types of catheters, cardiovascular catheters account for about 40.9% of the global catheter market.

This report analyzes the worldwide market for catheters for the period of 2010 to 2017. The in-depth research and high level analysis will allow catheters product manufacturers, service providers, marketing companies, research and development agencies to make informed decisions about catheters manufacturing, marketing, growth strategies and gaining competitive advantage.

Geographies Covered

- North America

- Europe

- Asia-Pacific

   - China

- Rest of the World (RoW)

Catheters Segments Covered

- Cardiovascular

- Neurovascular

- Intravenous

- Urological

- Specialty

Reasons to purchase this report

This research is specially designed to estimate and analyze the demand and performance of the global and China catheters market. The report covers all the major segments of catheters market and provides in-depth analysis, market revenue, and trend analysis by segments and statistically refined forecast for the segments covered. The report also provides:

- Definition, estimates & forecast for the global and China catheters market from 2010 to 2017

- Market forces driving and restraining the growth of the market

- Up-to-date analysis of the latest trends in the industry

- Leading industry opinion keeps you abreast of latest news and trends 

- Forward-looking outlook on a category, market or issue affecting the industry

- Make more informed business decisions from insightful and in-depth analysis of the market performance

Related & Recently Published Reports by Transparency Market Research

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com 

Browse the full report at http://www.transparencymarketresearch.com/catheters-market.html 

Read More